Synthesis of 3 -(1H -benzimidazol -2 -yl ) -5 -isoquinolin-4 -ylpyrazolo[1,2 -b]pyridine, a potent cyclin dependent kinase 1 (CDK1) inhibitor

Journal article

Peer reviewed

SHENLIN Huang, RONGHUI Lin, YANG YU, YANHUA LU, Peter J Connolly, George Chiu, SHENGJIAN LI, Stuart L Emanuel and Steven A Middleton

Bioorganic & medicinal chemistry letters, Vol.17(5), pp.1243-1245

01/03/2007

PMID: 17234412

Abstract

Antineoplastic agents

Biological and medical sciences

General aspects

Medical sciences

Pharmacology. Drug treatments

3 Record Views

Title: Synthesis of 3 -(1H -benzimidazol -2 -yl ) -5 -isoquinolin-4 -ylpyrazolo[1,2 -b]pyridine, a potent cyclin dependent kinase 1 (CDK1) inhibitor
Creators - without role: SHENLIN Huang - Johnson & Johnson Pharmaceutical Research & Development L. L. C., 1000 Route 202, Raritan, NJ 08869, United States
RONGHUI Lin - Johnson & Johnson Pharmaceutical Research & Development L. L. C., 1000 Route 202, Raritan, NJ 08869, United States
YANG YU - Johnson & Johnson Pharmaceutical Research & Development L. L. C., 1000 Route 202, Raritan, NJ 08869, United States
YANHUA LU - Johnson & Johnson
Peter J Connolly - Johnson & Johnson
George Chiu - Johnson & Johnson
SHENGJIAN LI - Johnson & Johnson
Stuart L Emanuel - Johnson & Johnson
Steven A Middleton - Johnson & Johnson
Publication Details: Bioorganic & medicinal chemistry letters, Vol.17(5), pp.1243-1245
Publisher: Elsevier
Identifiers: 9943852508331
Academic Unit: King Abdullah University of Science & Technology
Language: English
Resource Type: Journal article